PK20, a new opioid-neurotensin hybrid peptide that exhibits central and peripheral antinociceptive effects
<p>Abstract</p> <p>Background</p> <p>The clinical treatment of various types of pain relies upon the use of opioid analgesics. However most of them produce, in addition to the analgesic effect, several side effects such as the development of dependence and addiction as...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2010-12-01
|
| Series: | Molecular Pain |
| Online Access: | http://www.molecularpain.com/content/6/1/86 |